An interventional study of Probiotic and Placebo in Common Cold, sponsored by Lund University. Status unknown at 1 site in Sweden. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-12.
Sponsored by Lund University · Not applicable, Interventional, and Prevention
The purpose with this study is to investigate the preventative effect of a supplement containing a combination of probiotic bacteria and fungi as well as zinc on the common cold. The hypothesis is that it will shorten the duration, alleviate the severity of symptoms or even decrease the number of infectons during the intervention period. This study is a randomzed placebo controlled human study were healthy adults will consume the supplement for three months.
180 studies on the registry are indexed under Common Cold; 22 are open to participants now.
This study's planned enrollment of 100 is below the median of 167 across 151 interventional studies indexed under Common Cold.
Browse Common Cold studies →Lund University is the lead sponsor of 230 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Rice flour
Dietary Supplement: Placebo
Probiotic bacteria, yeast, zinc and rice brand
Dietary Supplement: Probiotic
The participants will consume 2 capsules daily for three months
The participants will consume 2 capsules daily for three months
Symptoms severity
Decrease in the severity of symptoms will be determined using a common cold questionnaire.
Time frame: Three months
Composition of gut and oral microbiome
Change in gut and oral microbiome will be measured using 16SrRNA and 18SrRNA sequencing
Time frame: Three months
IgA
Changes in levels of IgA in saliva and/or feces will be measured using ELISA
Time frame: Three months
Duration of symptoms
Decrease in duration of cold will be determined using a common cold questionnaire
Time frame: Three months
Number of colds
Decrease in number of colds will be determined using a common cold questionnaire
Time frame: Three months
Plan to share: No — Only group data will be shared
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lund University